ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE

Introduction and FDA Objectives, James MacGregor, PhD, FDA ppt html

Positron Emission Tomography: Nonclinical Aspects of Probe Development, Jerry M. Collins, Ph.D., FDA ppt html

SmithKline Beecham Pharmaceuticals, Gwyn Moran, PhD ppt html

CMC Issues for Screening INDs, Eric B. Sheinin, Ph.D., FDA ppt html